Oncology
Conditions
Brief summary
This study assesses the association between digital functional measures of physical and patient-reported standard onocological assessments, like Karnofsky Performance Score (KPS).
Detailed description
This study assess the association between digital functional measures from physical monitoring devices (devices like a watch tracking steps, a heart rate monitor) and patient-reported standard oncological assessments. The study will also test the feasibility of obtaining the measures in clinic and at home from the monitoring devices in participants with cancer. Participants will be asked to spend 1 hour in clinic performing simple tasks such as walking and standing with 7 digital devices recording movement data. The participants will also be asked to fill out survey data regarding their health. At-home data will be collected for 14 days. During this time participants will wear a watch to collect movement and step data, and a lumbar belt to collect movement data. Primary Objective: 1\. Assess the association of 5 main digital physical functional measures (mean steps per day, mean sedentary activity time, light activity time, moderate activity time, and vigorous activity time (in minutes) per day) recorded at home with patient-reported standard oncological assessment (e.g. KPS)
Interventions
OTHERDigital Physical Measures and Survey Assessments
Data from at home and in clinic visits will assess physical function and survey data will be collected
Sponsors
Pfizer
UNC Lineberger Comprehensive Cancer Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No
Inclusion criteria
1. All genders aged ≥ 18 years of age 2. Patients being seen at UNCCH for treatment of cancer. 3. English-speakers 4. Able to understand and cooperate with study procedures. 5. Patients with solid tumors or hematological malignancies, and self-reported KPS ≤70 to ≥ 100. Signed and dated informed consent and HIPPA.
Exclusion criteria
1. Subjects using investigational/experimental products. 2. Has dementia, altered mental status, or any psychiatric or co-morbid condition prohibiting the understanding or rending of informed consent. 3. Unable or unwilling to complete physical performance assessments including the at-home wearable device for 14 days. 4. Unable to speak English. 5. Subjects who report any other medical condition, recreational substance use, or medication use which would prevent them from completing study tasks or impair the providing of informed consent. 6. Subjects who are allergic to silicone or adhesives. Subjects with cardiac pacemakers, electronic pumps or any other implanted medical devices.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Amount of mean steps per day recorded at home | 18 months | At-home record of mean steps per day |
| Amount of mean sedentary activity time recorded at home | 18 months | At-home record of minutes per day of mean sedentary activity time |
| Amount of Light activity time recorded at home | 18 months | At-home record of minutes per day of light activity time per day |
| Amount of moderate activity time recorded at home | 18 months | At-home record of minutes per day of moderate activity time |
| Amount of vigorous activity time recorded at home | 18 months | At-home record of minutes per day of vigorous activity time |
| Self-Reported Karnofsky Performance Score (KPS) | 18 months | The validated 1 question Self-reported Karnofsky Performance Score (KPS) score 0 to 100 will be measured. Scores closer to 100 indicate high performance of the patient |
Countries
United States
Outcome results
None listed